Highwoods Properties, INC Research expand relationship

NewsGuard 100/100 Score

Highwoods Properties, Inc. (NYSE: HIW), the largest owner and operator of suburban office properties in the Southeast, today announced that it has expanded its relationship with INC Research®, Inc., a therapeutically focused contract research organization that conducts global clinical development programs. INC Research, which currently has 58,000 square feet under a long-term lease at 4800 North Park, another Highwoods owned property in Raleigh, has signed a second long-term lease for an additional 60,000 square feet at Highwoods Tower II.

Ed Fritsch, President and CEO of Highwoods stated, "We are pleased INC Research has chosen to expand its relationship with Highwoods and relocate a significant piece of its operations into another one of our properties. We value our relationship with INC Research and their distinguished management team and look forward to serving them for many years to come. Also, congratulations to our Raleigh team for their hard work in strengthening our relationship with INC Research."

Jim Ogle, CEO of INC Research said, "We remain committed to the state of North Carolina as the location of our global headquarters and look forward to continued growth not only in Raleigh but across our worldwide footprint at a rate that is supported by our customers' requirements. We are pleased to have worked with the Highwoods team to find a property that effectively meets the business needs of our organization."

Source:

 INC Research® Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings